Citation Impact
Citing Papers
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Hemoglobin A1c as a tool for the diagnosis of type 2 diabetes in 208 premenopausal women with polycystic ovary syndrome
2011
Primary Prevention of Coronary Heart Disease in Women through Diet and Lifestyle
2000 Standout
Estrogen receptors and human disease
2006 Standout
Association Between Puberty and Features of Nonalcoholic Fatty Liver Disease
2012
Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women
1998 Standout
Pathophysiology of sex hormone binding globulin (SHBG): Relation to insulin
1991
Prevalence and Control of Diabetes in Chinese Adults
2013 Standout
Dietary Intake and Bioavailability of Polyphenols
2000 Standout
Diabetes mellitus and risk of breast cancer: A meta‐analysis
2007
Cardiovascular Disease Outcomes During 6.8 Years of Hormone Therapy
2002 Standout
Racial/ethnic differences in survival rates in a population‐based series of men with breast carcinoma†
2002
Estrogen receptor α is a major mediator of 17β-estradiol’s atheroprotective effects on lesion size in Apoe–/– mice
2001 StandoutNobel
Impact of postmenopausal hormone therapy on cardiovascular events and cancer: pooled data from clinical trials
1997
Long-term DHEA substitution in female adrenocortical failure, body composition, muscle function, and bone metabolism: a randomized trial
2011
Alcohol and public health
2005 Standout
Male breast cancer: a retrospective study with immunohistochemical analysis of hormone receptor expression
1997
Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline
2016 Standout
Anabolic-Androgenic Steroids for Alcoholic Liver Disease: A Cochrane Review
2002
Long term hormone therapy for perimenopausal and postmenopausal women
2005
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
2013 Standout
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
Care of Girls and Women with Turner Syndrome: A Guideline of the Turner Syndrome Study Group
2006
Autoradiographic Localization and Characterization of Angiotensin II Receptors in the Bovine Placenta and Fetal Membranes1
1998
Estradiol inhibition of arterial neointimal hyperplasia after balloon injury
1994
Diabetes in Asia
2009 Standout
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms
2004 Standout
High densities of angiotensin II subtype 2 (AT2) receptors in the porcine placenta and fetal membranes
1996
Polycystic Ovary Syndrome
1995 Standout
Effect of pioglitazone on glucose metabolism and luteinizing hormone secretion in women with polycystic ovary syndrome
2006
Hepatocellular carcinoma in cirrhosis: Incidence and risk factors
2004 Standout
Syndrome X and Mortality: A Population-based Study
1998
High serum dehydroepiandrosterone sulfate is associated with phenotypic acne and a reduced risk of abdominal obesity in women with polycystic ovary syndrome
2010
Acromegaly: An Endocrine Society Clinical Practice Guideline
2014 Standout
A comparative metabolic study of two low-estrogen-dose oral contraceptives containing desogestrel or gestodene progestins
1993
Male breast cancer
2006 Standout
Acne vulgaris
2011 Standout
Polyphenols: food sources and bioavailability
2004 Standout
Prevalence of the Metabolic Syndrome Among US Adults
2002 Standout
Prevalence of endocrine diseases and abnormal glucose tolerance tests in 340 caucasian premenopausal women with hirsutism as the referral diagnosis
2004
Nutrition, hormones, and breast cancer: Is insulin the missing link?
1996
Biology and function of the reversible sulfation pathway catalysed by human sulfotransferases and sulfatases
1998
Metabolic Syndrome and Risk of Incident Cardiovascular Events and Death
2007 Standout
Estrogen plus Progestin and the Risk of Coronary Heart Disease
2003 Standout
Physiology of Local Renin-Angiotensin Systems
2006 Standout
Biological and Medical Significance of Calcium Phosphates
2002 Standout
Alcohol and Breast Cancer in Women
1998
Dehydroepiandrosterone in adrenal insufficiency and ageing
2008
Newer Anticonvulsants
2000
Regulation of 3β-Hydroxysteroid Dehydrogenase/Δ5-Δ4Isomerase Expression and Activity in the Hypophysectomized Rat Ovary: Interactions between the Stimulatory Effect of Human Chorionic Gonadotropin and the Luteolytic Effect of Prolactin*
1990
Hormonal Etiology of Epithelial Ovarian Cancer, With a Hypothesis Concerning the Role of Androgens and Progesterone
1998
Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets
2011 Standout
Impact of Informing Overweight Individuals about the Role of Genetics in Obesity: An Online Experimental Study
2013 Standout
On the Paradox of Insulin-Induced Hyperandrogenism in Insulin-Resistant States
1991
Cytochrome P450 ω-Hydroxylase Pathway of Tocopherol Catabolism
2002 Standout
Inhibition and induction of human cytochrome P450 (CYP) enzymes
1998
EVALUATING PATIENT'S KNOWLEDGE OF MATERNAL SERUM SCREENING
1996
Insulin Resistance Is Not Conserved in Myotubes Established from Women with PCOS
2010
Dioxin and Endometrial Progesterone Resistance
2010
Glycosylation in cancer: mechanisms and clinical implications
2015 Standout
Soluble CD36 Ectodomain Binds Negatively Charged Diacylglycerol Ligands and Acts as a Co-Receptor for TLR2
2009 StandoutNobel
Wine, alcohol, platelets, and the French paradox for coronary heart disease
1992 Standout
Collagen-calcium phosphate composites
1998
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Male breast carcinoma--a review of 301 cases from the Christie Hospital & Holt Radium Institute, Manchester
1985
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
The Impact of Glucocorticoid Replacement Regimens on Metabolic Outcome and Comorbidity in Hypopituitary Patients
2006
Pathophysiology of the Neuroregulation of Growth Hormone Secretion in Experimental Animals and the Human*
1998 Standout
Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline
2006 Standout
Impact of the Metabolic Syndrome on Mortality From Coronary Heart Disease, Cardiovascular Disease, and All Causes in United States Adults
2004 Standout
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
2015 Standout
Oral estrogen replacement therapy versus placebo for hot flushes: a systematic review
2001
The Insulin-Related Ovarian Regulatory System in Health and Disease
1999
Prolactin (PRL) and Its Receptor: Actions, Signal Transduction Pathways and Phenotypes Observed in PRL Receptor Knockout Mice
1998 Standout
The hypothalamus and reproduction
1972 StandoutNobel
C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events
2003 Standout
Male breast cancer: a review
1976
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis*
1997 Standout
Effects of chloro-s-triazine herbicides and metabolites on aromatase activity in various human cell lines and on vitellogenin production in male carp hepatocytes.
2001
Plasma estrogens and androgens in male breast cancer
1976
U.S. Medical Eligibility Criteria for Contraceptive Use, 2016
2016 Standout
Hormones and Endocrine-Disrupting Chemicals: Low-Dose Effects and Nonmonotonic Dose Responses
2012 Standout
Alterations in glycosylation as biomarkers for cancer detection
2010
Risk of liver and other types of cancer in patients with cirrhosis: A nationwide cohort study in Denmark
1998
Male Breast Cancer: A Population-Based Comparison With Female Breast Cancer
2009 Standout
Male Breast Cancer
1974
Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications
2012 Standout
Multidisciplinary Meeting on Male Breast Cancer: Summary and Research Recommendations
2010 Standout
Change in alcohol consumption and risk of death from all causes and from ischaemic heart disease.
1991
Regulation of the human menstrual cycle
1971
Normal basal and insulin-stimulated fuel metabolism in lean women with the polycystic ovary syndrome.
1993
Serum oestradiol-17 β, testosterone, luteinizing hormone and follicle-stimulating hormone in males with breast cancer
1980
Soluble CD36 and Risk Markers of Insulin Resistance and Atherosclerosis Are Elevated in Polycystic Ovary Syndrome and Significantly Reduced During Pioglitazone Treatment
2008
Breast Cancer in Men
2002 Standout
Antiatherogenic Effect of Estrogen Abolished by Balloon Catheter Injury in Cholesterol-Clamped Rabbits
1997
A case-control study of male breast cancer.
1988
Multiple Binding Modes of Inhibitors to Carbonic Anhydrases: How to Design Specific Drugs Targeting 15 Different Isoforms?
2012 Standout
Works of Birgit Svenstrup being referenced
Dehydroepiandrosterone supplementation in women with adrenal failure: impact on twenty‐four hour GH secretion and IGF‐related parameters
2004
ANGIOTENSIN II RECEPTOR DENSITY IN BOVINE OVARIAN FOLLICLES RELATES TO TISSUE RENIN AND FOLLICULAR SIZE
1994
Very short term dehydroepiandrosterone treatment in female adrenal failure: impact on carbohydrate, lipid and protein metabolism
2005
Maternal serum markers in screening for Down syndrome
1990
Comparative Trial of the Effects on Glucose Tolerance and Lipoprotein Metabolism of two New Oral Contraceptives Containing Gestoden and Desogestrel
1988
Simple Mucin-Type Carbohydrates in Normal and Malignant Human Endometrium
1995
Androgens and Estrogens in Postmenopausal Insulin-Treated Diabetic Women
1989
Reduced androgen levels in adult Turner syndrome: influence of female sex steroids and growth hormone status
1999
Possible Interaction Between Oxcarbazepine and an Oral Contraceptive
1992
Circulating sex hormones and gene expression of subcutaneous adipose tissue oestrogen and alpha‐adrenergic receptors in HIV‐lipodystrophy: implications for fat distribution
2007
Histamine-induced paradoxical GH response to TRH/GnRH in men and women: Dependence on gonadal steroid hormones
1990
Menopausal age and sex hormones in postmenopausal women with alcoholic and non-alcoholic liver disease
1991
Cortical bone mass, composition, and mechanical properties in female rats in relation to age, long-term ovariectomy, and estrogen substitution
1993
Steroid metabolism in the hormone dependent MCF-7 human breast carcinoma cell line and its two hormone resistant subpopulations and
1997
Estrogen- and progesterone receptors in normal cycling endometrium as studied by end-point titration
1994
Discontinuation of estrogen replacement therapy in GH-treated hypopituitary women alters androgen status and IGF-I
2005
Testis cancer. Ichthyosis constitutes a significant risk factor
1991
A two-year double-blind controlled study of the clinical effect of combined and sequential postmenopausal replacement therapy and steroid metabolism during treatment
1993
Hypothalamic–Pituitary–Gonadal Function in Relation to Liver Function in Men with Alcoholic Cirrhosis
1983
TREATMENT OF HYPERPROLACTINEMIC LUTEAL INSUFFICIENCY WITH BROMOCRIPTINE
1979
Dose-Dependent Effect of 17β-Estradiol Determined by Growth Curves and Flow Cytometric DNA Analysis of a Human Breast Carcinoma (T61) Grown in Nude Mice
1985
SERUM SEX HORMONE CONCENTRATIONS IN INSULIN DEPENDENT DIABETIC WOMEN WITH AND WITHOUT AMENORRHOEA
1985
Hormonal contraception in diabetic women: Acceptability and influence on diabetes control and ovarian function of a nonalkylated estrogen/progestogen compound
1985
ABNORMAL ANDROGEN AND OESTROGEN METABOLISM IN MEN WITH STEROID SULPHATASE DEFICIENCY AND RECESSIVE X‐LINKED ICHTHYOSIS
1985
Male breast cancer—II
1973
Sex hormones in postmenopausal women with primary biliary cirrhosis
1991
91224231 Menopausal age and sex hormones in postmenopausal women with alcoholic and non-alcoholic liver disease
1992
[Thyrotropin releasing hormone and serum levels of catecholamines as well as 11-hydroxycorticoids].
1971